AstraZeneca announced a voluntary recall of 34,524 bottles of Nexium (esomeprazole magnesium) delayed-release capsules following the discovery of a bottle containing Seroquel XR (quetiapine fumarate) extended-release tablets instead.
Gene therapy showed a significant benefit in lung function in patients with cystic fibrosis, data from a Phase 2 trial has shown.
The effect of statins on aggression appears to differ based on sex and age, as a study published in PLOS ONE found that aggression increased in postmenopausal women taking statins but actually decreased in men.
The Food and Drug Administration (FDA) has approved Orkambi (lumacaftor/ivacaftor; Vertex), the first and only drug indicated for the treatment of cystic fibrosis (CF) in patients aged ≥12 who are homozygous for the F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Teva announced the launch of Aspirin and Extended-Release Dipyridamole Capsules, the generic version of Aggrenox Capsules.